Please login to the form below

Not currently logged in
Email:
Password:

Tamiflu

This page shows the latest Tamiflu news and features for those working in and with pharma, biotech and healthcare.

Roche’s new flu pill Xofluza approved in US

Roche’s new flu pill Xofluza approved in US

Roche’ s new flu pill Xofluza approved in US. Hasn't shown superiority to Tamiflu. ... including those resistant to Roche’s now off-patent and former blockbuster flu treatment, Tamiflu.

Latest news

  • Encouraging data for Roche flu drug ahead of FDA decision Encouraging data for Roche flu drug ahead of FDA decision

    Tamiflu was a multi-billion dollar earner just a few years ago, but generic versions have now flooded onto the market. ... The pipeline drug will have to significantly outperform the now generic Tamiflu to gain traction.

  • Roche’s Tamiflu successor hits the mark in complicated flu Roche’s Tamiflu successor hits the mark in complicated flu

    Roche’ s Tamiflu successor hits the mark in complicated flu. Baloxavir marboxil met its primary objective and cut flu-related complications. ... Tamiflu has to be dosed twice-daily for five days, while the new drug is delivered as a one-day, one-dose

  • Long-serving R&D head Bischofberger to leave Gilead Long-serving R&D head Bischofberger to leave Gilead

    Austria-born Bischofberger - who rose to prominence as one of the inventors of Roche’s big-selling influenza drug Tamiflu (oseltamivir) - will leave the company fully in July after 28 years

  • The state of trust The state of trust

    Roche has a mixed background in this area. Its reticence over publishing clinical studies for its flu drug Tamiflu was one of the drivers behind the formation of AllTrials in 2013.

  • Tecentriq growth offsets Avastin's US decline at Roche Tecentriq growth offsets Avastin's US decline at Roche

    Roche is expecting some pressure in 2017 thanks in part to the loss of US patent protection for influenza drug Tamiflu (oseltamivir) in December 2016, exposing around $500m of the

More from news
Approximately 9 fully matching, plus 97 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics